TRYPTAMINE THERAPEUTICS LIMITED - Charts / Financials

5.56%

3.4¢

Currently unlisted.

Healthcare Biotechnology

Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology... Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. It is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. Its lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin It intends to accomplish this through the development of an IV infusion of psilocin Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. It has completed phase II clinical trials for the treatment of binge eating disorder. Its pipeline products include TRP-8803 and TRP-8802.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

REFRESH

Day chart unavailable

Last update - 15.54pm 20/11/2025 (20 minute delay)

Day
Open	3.5¢		Day High	3.5¢		Day Low	3.2¢
Daily Volume	3581233

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	3.3¢	1343036		1	3.4¢	226975

Directors & Senior Management

Mr. Christopher Ntoumenopoulos	Executive Director
Dr. Daniel Tillet	Non-Executive Director
Mr. Gage Jull	Non-Executive Director
Mr. Hamish George	Chief Financial Officer, Company Secretary
Mr. Herwig Janssen	Non-Executive Chairman of the Board
Mr. Jason Alan Carroll	Chief Executive Officer, Director

Data source: ADVFN

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

TRYPTAMINE THERAPEUTICS LIMITED - Charts / Financials

Corporate SpotlightNot Yet Available

Directors & Senior Management

Top Stories

Corporate Spotlight
Not Yet Available